Rejection medication and immunotherapy fight cancer and protect kidney transplants
The addition of immunotherapy to standard anti-rejection medication could change the lives of thousands of kidney transplant patients with incurable cancer, as new research shows that it can reduce this risk of organ rejection and eliminate cancer in a a quarter of patients. Conducted by researchers at Royal Adelaide Hospital and the University of South …
Rejection medication and immunotherapy fight cancer and protect kidney transplants Read More »